Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial
Titel:
Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial
Auteur:
Le Page, Emmanuelle Veillard, David Laplaud, David A Hamonic, Stéphanie Wardi, Rasha Lebrun, Christine Zagnoli, Fabien Wiertlewski, Sandrine Deburghgraeve, Véronique Coustans, Marc Edan, Gilles